Repligen today entered an agreement to acquire FlexBiosys Inc. of Branchburg, NJ. The acquisition is another step in building out Repligen’s Fluid Management franchise, adding a full range of single-use bioprocessing bags and assemblies to our product offering. The addition of FlexBiosys complements and vertically integrates our systems offering, providing a more complete single-use fluid management portfolio of products for our biopharmaceutical manufacturing customers.
FlexBiosys will complete qualification of State of the Art, custom 3D bag manufacturing equipment during Q1, 2023. The equipment will increase 3D bag manufacturing capacity while maintaining the superior product robustness, quality and functionality that our customer demand for their applications.
Interphex 2023, April 25-27, please join us at the Javits Center, NYC, Stay tuned for details!
FlexBiosys moved into a 22,400 square foot facility with a 7,500 sq. ft. ISO Class 7 cleanrooom in September of 2022!